Australian researchers have found a new biomarker for multiple myeloma that could help doctors rapidly identify patients at greatest risk of poor outcomes, enabling more personalized and effective treatments. Multiple myeloma ...
Jul 21, 2026
0
7
Researchers presented an artificial intelligence (AI)-guided technique at the Society of NeuroInterventional Surgery's (SNIS) 23rd Annual Meeting that may improve the accuracy of delivering experimental therapies directly ...
Jul 21, 2026
0
4
Chronic, low-grade inflammation in the body—a phenomenon known as "inflammaging" because it increases with age—has been linked to many of today's leading causes of illness and death, including cancer, heart disease, metabolic ...
Jul 21, 2026
0
58
Megan (not her real name) had always taken pride in her ability to meet someone once and remember their name. Then came a breast cancer diagnosis in her 40s, chemotherapy and the brain fog that followed. She struggled to ...
Jul 20, 2026
0
5
Researchers have uncovered a clue to why immune checkpoint inhibitors—cancer therapies that release the immune "brakes" exploited by tumors to evade attack—show limited efficacy in some brain tumors. A KAIST research team ...
Jul 20, 2026
0
15
In a phase 2 clinical trial, Mass General Brigham Cancer Institute researchers found that the oral drug avatrombopag was safe and effective in managing persistent chemotherapy-induced thrombocytopenia (CIT) in more than half ...
Jul 20, 2026
0
3
A Mayo Clinic study published in JAMA Network Open found that bringing some or all clinical trial-related activities directly to patients can help overcome barriers that prevent many people from participating. Increased participation ...
Jul 20, 2026
0
2
Significant advances have been made in the development of patient-derived tumor "organoids" for preclinical research in two new studies led by Weill Cornell Medicine investigators. Organoids are three-dimensional clumps of ...
Jul 20, 2026
0
3
A noninvasive DNA blood test can identify patients with metastatic castration-resistant prostate cancer (mCRPC) who are most likely to benefit from 223Ra radiopharmaceutical therapy and monitor their progress throughout treatment, ...
Jul 20, 2026
0
5
Weill Cornell Medicine investigators have developed a new AI-based method to assess patients with a form of blood cancer called myelodysplastic neoplasms. The method, published June 30 in Leukemia, compares the physical locations ...
Jul 20, 2026
0
7
